Want to join the conversation?
David MacGregor of Longbow Research wants to know about the impact of startup costs on $MHK's 2Q16 margins. CEO Jeff Lorberbaum replied that startup costs in 2Q16 were about $4MM and the company is estimating about another $3-5MM in startup through 2H16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?